Helen Springford
Directeur Général chez Illingworth Research Group Ltd.
Profil
Helen Springford is currently the Chief Executive Officer at Illingworth Research Group Ltd.
and the Vice President-Global Client Relations at Pharm-Olam International Ltd.
She previously worked as the VP-Global Business Development at Remedium Oy and as the Vice President-Business Development at Encorium Group, Inc.
Postes actifs de Helen Springford
| Sociétés | Poste | Début |
|---|---|---|
Pharm-Olam International Ltd.
 Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | Corporate Officer/Principal | 11/11/2009 |
Illingworth Research Group Ltd.
 Illingworth Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Illingworth Research Ltd. operates as a clinical research organization. The company is headquartered in Macclesfield, the United Kingdom. | Directeur Général | - |
Anciens postes connus de Helen Springford
| Sociétés | Poste | Fin |
|---|---|---|
Remedium Oy
 Remedium Oy Miscellaneous Commercial ServicesCommercial Services Remedium Oy is a clinical research organisation providing clinical research services to pharmaceutical, food and biotech companies. Remedium areas of expertise are cardiology and cardiovascular diseases, oncology, immunology and vaccines, CNS, endocrinology and medical devices. The company is headquartered in Espoo, Finland | Corporate Officer/Principal | 30/10/2006 |
Encorium Group, Inc.
 Encorium Group, Inc. Miscellaneous Commercial ServicesCommercial Services Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Remedium Oy
Remedium Oy Miscellaneous Commercial ServicesCommercial Services Remedium Oy is a clinical research organisation providing clinical research services to pharmaceutical, food and biotech companies. Remedium areas of expertise are cardiology and cardiovascular diseases, oncology, immunology and vaccines, CNS, endocrinology and medical devices. The company is headquartered in Espoo, Finland | Commercial Services |
Encorium Group, Inc.
Encorium Group, Inc. Miscellaneous Commercial ServicesCommercial Services Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania. | Commercial Services |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | Commercial Services |
Illingworth Research Group Ltd.
Illingworth Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Illingworth Research Ltd. operates as a clinical research organization. The company is headquartered in Macclesfield, the United Kingdom. | Commercial Services |
